Peripheral Arterial Disease: A Missed Opportunity to Administer Statins so as to Reduce Cardiac Morbidity and Mortality

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|12|4|443-452

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.4, 2005-02, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins reduce cardiac mass in patients with angina

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Cilostazol and peripheral arterial disease

By Pearce Lyndsay   Ghosh Jonathan   Counsell Andrew   Serracino-Inglott Ferdinand  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2683-2690

Informa Healthcare

Access to resources Recommend Favorite

Hypertension in Peripheral Arterial Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3615-3620

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants in Peripheral Arterial Disease

By  

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 651-655

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs in peripheral arterial disease

By Tulsyan Nirman   Ouriel Kenneth   Kashyap Vikram S  

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 75-90

Informa Healthcare

Access to resources Recommend Favorite